| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |